Literature DB >> 32387201

Current management of portal vein thrombosis in liver transplantation.

Prashant Bhangui1, Eduardo S M Fernandes2, Fabrizio Di Benedetto3, Dong-Jin Joo4, Silvio Nadalin5.   

Abstract

Nontumoral portal vein thrombosis (PVT) is present at liver transplantation (LT) in 5-26% of cirrhotic patients, and is known to affect post LT outcomes. Up to 31% of patients who are found to have PVT at the time of LT, would have had PVT at the time of initial listing, but others develop PVT during the waiting period. Adequate screening and treatment of the PVT on the waiting list for LT is thus essential so that a portoportal anastomoses can be performed at the time of LT. Early PVT (Yerdel Grade I/II) can be usually managed by thrombectomy, whereas Grade III PVT may require a jump graft from the superior mesenteric vein to the graft PV. Complete portomesenteric thrombosis is a huge challenge, and sometimes a cause for denying a LT in these patients, with multivisceral transplant being the only alternative. The presence of spontaneous, or previously surgically created portosytemic shunts like the leinorenal shunt, may serve as a good inflow option (renoportal anastomosis) in these patients to establish a physiological reconstruction. Although challenging, good outcomes are possible in patients with complex PVT if the appropriate surgical technique is chosen to ensure portal inflow and resolution of PHT post LT.
Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intraoperative management; Outcomes; PVT grade; Physiological reconstruction; Portal vein thrombosis

Mesh:

Year:  2020        PMID: 32387201     DOI: 10.1016/j.ijsu.2020.04.068

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  LncRNA Snhg1 Plays an Important Role via Sequestering rno-miR-139-5p to Function as a ceRNA in Acute Rejection After Rat Liver Transplantation Based on the Bioinformatics Analysis.

Authors:  Wu Wu; Menghao Wang; Chunming Li; Zhu Zhu; Yang Zhang; Di Wu; Zhibing Ou; Zuojin Liu
Journal:  Front Genet       Date:  2022-06-02       Impact factor: 4.772

Review 2.  Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?

Authors:  Marco Biolato; Mattia Paratore; Luca Di Gialleonardo; Giuseppe Marrone; Antonio Grieco
Journal:  World J Hepatol       Date:  2022-04-27

Review 3.  The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow's Triad.

Authors:  Aina Anton; Genís Campreciós; Valeria Pérez-Campuzano; Lara Orts; Joan Carles García-Pagán; Virginia Hernández-Gea
Journal:  J Clin Med       Date:  2022-02-02       Impact factor: 4.241

4.  Portal vein-variceal anastomosis for portal vein inflow reconstruction in orthotopic liver transplantation: A case report and review of literature.

Authors:  Aviad Gravetz
Journal:  World J Transplant       Date:  2022-07-18

5.  Auxiliary two-staged partial resection liver transplantation.

Authors:  Pål-Dag Line; Silvio Nadalin; Deniz Balci
Journal:  BMC Surg       Date:  2021-05-28       Impact factor: 2.102

6.  Liver transplantation and hepatobiliary surgery in 2020.

Authors:  Burcin Ekser; Karim J Halazun; Henrik Petrowsky; Deniz Balci
Journal:  Int J Surg       Date:  2020-07-19       Impact factor: 13.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.